image
NeoGenomics, Inc. NEO
Healthcare - Medical - Diagnostics & Research - NASDAQ - US
Watchlist
$ 15.04
-4.75 %
$ 1.93 B
Market Cap
-24.66
P/E
CASH FLOW STATEMENT
-1.95 M OPERATING CASH FLOW
97.04%
Growth Rates
1Year 97.04%
3Years -32.72%
5Years -0.86%
7Years -1.25%
10Years -6.50%
76.7 M INVESTING CASH FLOW
14736.94%
Growth Rates
1Year 14736.94%
3Years 35.38%
5Years 20.58%
7Years 45.49%
10Years 44.66%
4.55 M FINANCING CASH FLOW
-61.50%
Growth Rates
1Year -61.50%
3Years -73.16%
5Years -45.18%
7Years 11.75%
10Years 5.17%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis NeoGenomics, Inc.
image
Net Income -88 M
Depreciation & Amortization 72.6 M
Capital Expenditures -28.8 M
Stock-Based Compensation 24.6 M
Change in Working Capital -25.5 M
Others 5.32 M
Free Cash Flow -30.7 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Mar-2008 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000
OPERATING CASH FLOW
Net Income (88.0) (144.2) (8.3) 4.2 8.0 2.6 (0.8) (5.7) (2.5) 1.1 2.0 65 K (1.2) (3.3) (2.2) (1.4) (3.4) (0.1) (1.0) (0.8) (0.5) (0.6) (8.1) (1.0)
Depreciation & Amortization 72.6 69.4 53.4 35.7 30.3 21.7 22.6 23.2 7.1 5.6 4.4 3.8 2.1 1.8 1.2 0.7 0.5 0.3 0.2 0.1 48 K (0.2) 0.2 26.4 K
Deferred Income Tax 0 (16.1) (103.2) 1.0 1.5 0.4 20.0 15.3 (2.1) 2.4 2.8 3.1 0 49 K 68.6 K 0.3 0 0 0 0 0 0 0 0
Stock Based Compensation 24.6 24.7 22.5 10.2 10.0 7.0 6.4 5.4 3.5 0.7 0.9 0.8 0.5 0.4 0.4 0.2 0 0 0 0 0 0 0 0
Other Operating Activities 14.3 32.0 13.6 12.2 6.0 0.5 0.4 4.6 2.3 66 K 49 K 38 K 2.6 2.5 2.2 1.9 1.4 0.6 0.3 35.2 K 46.7 K 0.2 7.7 0.2
Change in Working Capital (25.5) (31.7) (4.6) (61.7) (32.4) 12.5 (30.5) (21.4) (1.9) (0.5) (8.0) (8.3) (3.9) (3.4) (3.1) (1.9) (1.2) (1.5) (0.4) 21.4 K 91.4 K 0.2 13.4 K 0.6
Cash From Operations (2.0) (66.0) (26.7) 1.5 23.4 44.8 18.0 21.5 6.4 9.4 2.2 (0.5) 69 K (2.1) (1.5) (0.1) (2.6) (0.7) (0.9) (0.7) (0.5) (0.4) 77.4 K (0.2)
INVESTING CASH FLOW
Capital Expenditures (28.8) (30.9) (64.1) (29.1) (20.0) (14.3) (13.7) (7.5) (2.2) (3.8) (2.0) (3.7) (0.9) (0.9) (1.0) (0.5) (0.5) (0.4) (0.1) 85.9 K 63.2 K (0.4) 2.9 K 0
Other Items 105.5 31.4 (568.2) (130.3) 0.4 (125.4) 0 1.0 (72.9) (5.8) 0 0 0 0 0 0 (0.2) 0 0 0 0 0 209 0
Cash From Investing Activities 76.7 0.5 (632.4) (159.4) (19.6) (139.7) (13.7) (6.5) (75.2) (9.6) (2.0) (3.7) (0.9) (0.9) (1.0) (0.5) (0.7) (0.4) (0.1) 85.9 K 63.2 K (0.4) 2.69 K 0
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 (50.1) 0 (55.0) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Debt Repaid 70 K 0 331.4 91.3 (12.5) 5.1 (6.7) 27.6 60.9 (7.9) (2.6) 2.4 (1.1) 1.8 (1.1) 0.8 (0.2) 0.1 0 0 0 0 0 5.86 K
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 (0.8) (29.3) (3.3) 0 (57.2) 0 (57.2) (2.4) 2.6 5.4 1.0 0 0.5 (1.0) 0 (1.7) 0 0.7 91.3 K 0.6 0.7 0.2 0.1
Cash From Financing Activities 4.6 11.8 725.3 235.6 159.5 92.0 (4.1) (25.9) 58.5 29.0 2.8 3.4 2.4 2.4 3.6 0.9 3.4 1.2 0.9 0.8 0.6 0.7 0.2 0.1
CHANGE IN CASH
Net Change In Cash 79.3 (53.6) 66.2 77.6 163.2 (3.0) 0.3 (10.9) (10.3) 28.9 3.0 (0.8) 1.5 (0.5) 1.2 0.3 84.3 K 0.1 (0.1) 87.5 K 25.1 K 77.2 K 77.2 K 43.4 K
FREE CASH FLOW
Free Cash Flow (30.7) (96.9) (90.9) (27.6) 3.3 30.5 4.3 13.9 4.2 5.7 0.2 (4.1) (0.8) (3.0) (2.5) (0.6) (3.2) (1.1) (1.0) (0.7) (0.6) (0.8) 80.3 K (0.2)